Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by. My name is Danika and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Ligand Third Quarter 2023 Earnings Webcast.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Japan ,New York ,United States ,China ,Xintong ,Guizhou ,Beijing ,Boston ,Massachusetts ,Chinese ,Primrose Bio ,Novan Sitavig ,Jack Cole ,Matthew Korenberg ,Amgen Kyprolis ,Todd Davis ,Martine Zimmermann ,Keith Marschke ,Lawrence Solow ,Simon Latimer ,Matt Hewitt ,Larry Solow ,Tavo Espinoza ,Matt Korenberg ,Provention Bio ,Asia Pacific ,Adam Schefter ,Paul Hadden ,Robin Arzon ,Amgen ,Ligand Pharmaceuticals Incorporated ,Novartis ,European Bank Stocks To Invest ,Business Development ,Ligand Pharmaceuticals Inc ,Our Senior Management Team ,Call Transcript November ,Pharmaceuticals Incorporated ,Ligand Third Quarter ,Vice President ,Analyst Day ,Senior Management Team ,Viking Therapeutics ,Senior Vice President ,Lauren Hay ,Strategic Planning ,Investment Analytics ,Investment Analysis ,Primordial Genetics ,Ovid Therapeutics ,Tolerance Therapeutics ,New England Journal ,Prevention Bio ,Fitness Programming ,Both Verona ,With Filspari ,Investor Day ,Micro Cap Stocks To Invest ,